ASHLEY FERREIRA: Open Payments
NPI 1023796703 · MIDDLETOWN, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,766 in 71 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $356 · 2025 $1,766
Food & beverage: $1,471Education: $295
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 2 | $243 |
| Janssen Biotech, Inc. | 4 | $235 |
| Regeneron Healthcare Solutions, Inc. | 7 | $221 |
| Amgen Inc. | 6 | $180 |
| LEO Pharma Inc. | 7 | $178 |
| ABBVIE INC. | 19 | $153 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $151 |
| SANOFI-AVENTIS U.S. LLC | 1 | $100 |
| Novartis Pharmaceuticals Corporation | 5 | $83 |
| PFIZER INC. | 3 | $79 |
Products named: DUPIXENT, NEMLUVIO, TREMFYA, OTEZLA, ADBRY, SKYRIZI, CIBINQO, COSENTYX.
Industry payments across RI — which companies pay providers there.
